Altimmune Inc (ALT)
6.89
-0.15
(-2.13%)
USD |
NASDAQ |
Apr 18, 16:00
6.86
-0.03
(-0.44%)
After-Hours: 20:00
Altimmune Market Cap: 488.47M for April 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 17, 2024 | 499.10M |
| April 16, 2024 | 533.13M |
| April 15, 2024 | 535.26M |
| April 12, 2024 | 566.45M |
| April 11, 2024 | 595.52M |
| April 10, 2024 | 567.87M |
| April 09, 2024 | 595.52M |
| April 08, 2024 | 610.41M |
| April 05, 2024 | 644.44M |
| April 04, 2024 | 630.97M |
| April 03, 2024 | 658.62M |
| April 02, 2024 | 663.23M |
| April 01, 2024 | 725.26M |
| March 28, 2024 | 721.71M |
| March 27, 2024 | 630.26M |
| March 26, 2024 | 613.24M |
| March 25, 2024 | 604.74M |
| March 22, 2024 | 643.73M |
| March 21, 2024 | 643.87M |
| March 20, 2024 | 660.13M |
| March 19, 2024 | 617.72M |
| March 18, 2024 | 641.75M |
| March 15, 2024 | 696.88M |
| March 14, 2024 | 708.54M |
| March 13, 2024 | 771.09M |
| Date | Value |
|---|---|
| March 12, 2024 | 768.26M |
| March 11, 2024 | 697.59M |
| March 08, 2024 | 734.34M |
| March 07, 2024 | 708.89M |
| March 06, 2024 | 805.02M |
| March 05, 2024 | 794.41M |
| March 04, 2024 | 780.99M |
| March 01, 2024 | 854.49M |
| February 29, 2024 | 855.20M |
| February 28, 2024 | 938.60M |
| February 27, 2024 | 976.05M |
| February 26, 2024 | 800.07M |
| February 23, 2024 | 650.23M |
| February 22, 2024 | 626.91M |
| February 21, 2024 | 580.97M |
| February 20, 2024 | 593.69M |
| February 16, 2024 | 619.13M |
| February 15, 2024 | 632.56M |
| February 14, 2024 | 636.80M |
| February 13, 2024 | 597.93M |
| February 12, 2024 | 735.04M |
| February 09, 2024 | 737.87M |
| February 08, 2024 | 684.86M |
| February 07, 2024 | 731.51M |
| February 06, 2024 | 752.01M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
23.47M
Minimum
Nov 19 2019
1.099B
Maximum
Sep 02 2022
357.16M
Average
359.01M
Median
Market Cap Benchmarks
| Eli Lilly and Co | 708.23B |
| Amgen Inc | 140.79B |
| Viking Therapeutics Inc | 6.502B |
| Precision BioSciences Inc | 74.14M |
| Terns Pharmaceuticals Inc | 297.72M |
Market Cap Related Metrics
| PS Ratio | 861.05 |
| Price to Book Value | 2.517 |
| Price | 6.89 |
| Earnings Yield | -24.24% |